The global rheumatoid arthritis treatment market is expected to see significant growth in 2022. Rheumatoid arthritis is a chronic autoimmune disorder that causes inflammation and pain in the joints, leading to disability and reduced quality of life. The disease is typically treated with a combination of medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologic agents.
The increasing prevalence of rheumatoid arthritis, along with the growing awareness of the disease and the availability of effective treatments, is driving the growth of the rheumatoid arthritis treatment market. Additionally, the development of new and more effective treatments, as well as the increasing adoption of personalized medicine, is also supporting market growth.
Request For Free Sample Report of “Rheumatoid Arthritis Treatment Market”@ https://www.persistencemarketresearch.com/samples/22555
Rising occurrence of rheumatoid arthritis because of shift toward unhealthy lifestyle as well as increasing research & development activities for better and permanent therapy alternatives for rheumatoid arthritis treatment in order to diminish repeat rates are supporting market development. Rheumatoid arthritis is related with the immune system that leads to inflammation in the joints of the body, and later on the disease affects the muscles, fibrous tissues, tendons, and connective tissues. The load of rheumatoid arthritis (RA), currently incurable and an unending autoimmune disease that basically attacks the joints, is prominent. In 2020, approximately 4.9 million individuals across major regions were affected by rheumatoid arthritis. Manufacturers are focusing on partnerships and expansion of product portfolio by launching technologically advanced products and receiving approval from different government bodies.
The global rheumatoid arthritis treatment market is estimated to be valued at US$ 40.5 Bn in 2021, and is expected to exhibit a CAGR of around 6% over the forecast period (2021 – 2031).
Key Takeaways from Market Study
- Under therapy, DMARDs hold maximum value share, owing to increasing awareness associated with their utilization.
- By distribution channel, hospital pharmacies hold a notable revenue share of more than 75% in the market.
- The market North America accounted for a share of over 40% in 2020, and is expected to experience significant growth over the next ten years.
- Europe is the next dominating region with a market share of 28% in 2020, due to well-developed healthcare infrastructure largely supported by the government.
“Rise in prevalence of rheumatoid arthritis along with increase in adoption of DMARD therapies, flourishing combination treatment, and supportive government policies are expected to drive market growth,” says a Persistence Market Research analyst.
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/22555
Market by Segmentation by Category
By Therapy
- Symptomatic Treatment
- Intermediate Corticosteroid Therapies
- Stem Cell Therapy/ Cell Therapy
- Disease Modifying Anti-rheumatic Drug (DMARD)
- Conventional DMARDs
- Biological DMARDs
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
Request Customization @ https://www.persistencemarketresearch.com/request-customization/22555
Key Questions Answered in Report
Which is the most lucrative market for rheumatoid arthritis treatment?
The U.S. currently leads the global market for rheumatoid arthritis treatment. Sales in the U.S will be more than 40% of total demand in the world over the forecast period.
Which is the most preferred rheumatoid arthritis therapy?
DMARDs are highly sought-after in every market. Demand for DMARDs is expected to remain high in the near future, especially due to increasing awareness associated with their utilization.
Which distribution channel accounts for maximum revenue?
Hospital pharmacies continue to remain the leading sales channel for rheumatoid arthritis drugs. Utilization of recommended therapies in clinics and hospitals assist with overseeing a prescribed drug conveyance by a doctor securely, is one of the major factor driving the hospital pharmacies segment.
Which are some of the leading companies offering rheumatoid arthritis treatment equipment?
Some of the leading companies offering rheumatoid arthritis treatment equipment are Sanofi S.A., Pfizer Inc., Johnson & Johnson, AbbVie Inc., Eli Lilly & Company, Amgen Inc., and Bristol-Myers Squibb Company.
Other Trending Reports:
Next Generation Centrifuge Market
Plastic Wound Retractors Market
Cloud-based Drug Discovery Platforms Market
Dental Radiology Equipment Market
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com